Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4593964
Max Phase: Preclinical
Molecular Formula: C38H60N4O7
Molecular Weight: 684.92
Molecule Type: Unknown
Associated Items:
ID: ALA4593964
Max Phase: Preclinical
Molecular Formula: C38H60N4O7
Molecular Weight: 684.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CO/C1=C\CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@@H]2C[C@H](OCc3cn(CC4CCCCC4)nn3)O[C@@H]12
Standard InChI: InChI=1S/C38H60N4O7/c1-26-21-30-22-37(45-25-31-24-42(40-39-31)23-29-14-10-8-11-15-29)49-38(30)34(44-6)18-19-35(43)46-27(2)13-9-7-12-16-33(26)48-36-20-17-32(41(4)5)28(3)47-36/h7,9,12,16,18,24,26-30,32-33,36-38H,8,10-11,13-15,17,19-23,25H2,1-6H3/b9-7+,16-12+,34-18-/t26-,27-,28-,30-,32+,33+,36+,37-,38-/m1/s1
Standard InChI Key: BZBWPTZBWHUWGK-IDLQJWNSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 684.92 | Molecular Weight (Monoisotopic): 684.4462 | AlogP: 6.34 | #Rotatable Bonds: 9 |
Polar Surface Area: 106.40 | Molecular Species: BASE | HBA: 11 | HBD: 0 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: 9.26 | CX LogP: 5.86 | CX LogD: 4.00 |
Aromatic Rings: 1 | Heavy Atoms: 49 | QED Weighted: 0.27 | Np Likeness Score: 0.83 |
1. Klich K, Pyta K, Kubicka MM, Ruszkowski P, Celewicz L, Gajecka M, Przybylski P.. (2016) Synthesis, Antibacterial, and Anticancer Evaluation of Novel Spiramycin-Like Conjugates Containing C(5) Triazole Arm., 59 (17): [PMID:27501415] [10.1021/acs.jmedchem.6b00764] |
Source(1):